Mon, April 17, 2023
Sun, April 16, 2023
Fri, April 14, 2023
Thu, April 13, 2023
Wed, April 12, 2023
Tue, April 11, 2023

Mani Foroohar Maintained (BBIO) at Buy with Increased Target to $27 on, Apr 13th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-27-on-apr-13th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Mani Foroohar of SVB Securities, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Increased Target from $25 to $27 on, Apr 13th, 2023.

Mani has made no other calls on BBIO in the last 4 months.



There are 4 other peers that have a rating on BBIO. Out of the 4 peers that are also analyzing BBIO, 0 agree with Mani's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Mani


  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $23 on, Tuesday, March 7th, 2023
  • Dane Leone of "Raymond James" Maintained at Buy with Increased Target to $29 on, Tuesday, March 7th, 2023
  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $28 on, Tuesday, March 7th, 2023
  • Tyler Van Buren of "Cowen & Co." Initiated at Buy on, Monday, February 6th, 2023

Publication Contributing Sources